Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy

Annals of Oncology

Volumn 7, Issue 7, 1996, Pages 695-703

  Pelosio, P ^a   Barbareschi, M ^b   Bonoldi, E ^c   Marchetti, A ^d   Verderio, P ^e   Caffo, O ^b   Bevilacqua, P ^c   Boracchi, P ^e   Buttitta, F ^d   Barbazza, R ^a   Dalla Palma, P ^b   Gasparini, G ^c  

^a GENERAL HOSPITAL   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast cancer; Cyclin D1; p53; Prognosis

Indexed keywords

CYCLIN D1; CYCLINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; PROTEIN P53; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029812072     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010718     Document Type: Article

References (46)

1. 1-phase progression: Cyclin on cue. Cell 1994; 79: 551-5.
2. Pardee AB. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 1974; 71: 1286-90.
3. Strauss M, Lukas J, Bartek J et al. Unrestricted cell cycling and cancer. Nature Med 1995; 1: 1245-6.
4. Betticher DC. Cyclin D1, another molecule of the year? Ann Oncol 1996; 7: 223-5.
5. Bartkova J, Lukas J, Muller H. Cyclin-D1 protein expression and function in human breast cancer. Int J Cancer 1994; 57: 353-61.
6. Schuuring E, Verhoeven E, Van Tinteren H et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992; 52: 5229-34.
7. Weinstat-Saslow D, Merino MJ, Manrow RE et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med 1995; 1: 1257-60.
8. Sicinski P, Donaher JL, Parker SB et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995; 82: 621-30.
9. Bartkova J, Lukas J, Strauss M et al. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995; 10: 775-8.
10. McIntosh GG, Anderson JJ, Milton I et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995; 11: 885-91.
11. Gillett C, Fantl V, Smith R et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54: 1812-7.
12. Gillett CE, Smith P, Gregory WM et al. Cyclin D1 and prognosis in breast acancer. Int J Cancer (Pred Oncol) 1996; 69: 92-9.
13. Zhang SY, Camano J, Cooper F et al. Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 1994; 102: 695-8.
14. Buckley MF, Sweeney KJE, Hamilton et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993; 8: 2127-33.
15. Michalides R, Hageman P, Van Tinteren H et al. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1996; 73: 728-34.
16. Gasparini G, Barbareschi M, Boracchi P et al. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am 1995; 1: 131-41.
17. Fisher ER, Gregorio RM, Fisher B. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (Protocol no. 4). Cancer 1975; 36: 1-85.
18. Bloom HG, Richardson WW. Histological grading and prognosis. Br J Cancer 1957; 11: 359-77.
19. Gasparini G, Weidner N, Bevilacqua P et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994; 12: 454-66.
20. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eucaryotes. Nucl Acid Res 1976; 3: 2303-8.
21. Breslow NE, Day NE. Statistical methods in cancer research. In International Agency for Research on Cancer (ed): I.A.R.C. Scientific Publ. No. 32, Vol. 1. Lyon, France: World Health Organization 1980.
22. Choen J. A coefficient for agreement for nominal scales. Educ Psyc Meas 1960; 20: 37-47.
23. Peduzzi P, Concato J, Feinstein AR et al. Importance of events per independent variables in population hazards regression analysis II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995; 48: 1503-10.
24. Gasparini G, Fox SB, Verderio P et al. Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients. Clin Cancer Res 1996; 2: 1191-8.
25. Harrell FE, Califf RM, Pryor DB et al. Evaluating the yield of medical tests. JAMA 1982; 247: 2543-8.
26. 1 to complete the cell cycle. Proc Natl Acad Sci USA 1994; 91: 8022-6.
27. Zhou P, Jiang W, Weghorst CM et al. Overexpression of cyclin D1 enhances gene amplification. Cancer Res 1996; 56: 36-9.
28. Musgrove EA, Hamilton JA, Lee CSL et al. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 1993; 13: 3577-87.
29. Sutherland RL, Hamilton JA, Sweeney KJE et al. Expression and regulation of cyclin genes in breast cancer. Acta Oncol 1995; 34: 651-6.
30. Adnane J, Gundray P, Simon M-P et al. Proto-oncogene amplification and human breast cancer tumor phenotype. Oncogene 1989; 4: 1389-95.
31. Fantl V, Richards MA, Smith R et al. Amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur J Cancer 1990; 26: 423-9.
32. Worsely SD, Jennings BA, Khalil KH et al. Cyclin D-1 amplification and expression in human breast carcinoma: Correlation with histological prognostic markers and oestrogen receptor expression. J Clin Pathol: Mol Pathol 1996; 49: M46-M50.
33. 1 phase of the cell cycle. Cell 1991; 65: 701-13.
34. Grana X, Reddy P. Cell cycle control in mammalian cells: Role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995; 11: 211-9.
35. Ko TC, Sheng HM, Reisman D et al. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 1995; 10: 177-84.
36. Chen X, Bargonetti J, Prives C. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res 1995; 55: 4257-63.
37. Spitowski D, Steiner P, Gopalkrishnann R et al. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and EiB oncogenes. Oncogene 1995; 10: 2421-5.
38. Marhin WW, Hei YJ, Chen SJ et al. Loss of RB and Myc activation co-operate to suppress cyclin D1 and contribute to transformation. Oncogene 1996; 12: 43-52.
39. Daksis JI, Lu R, Facchini L, Marhin WW et al. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to cell cycle. Oncogene 1994; 9: 3635-45.
40. Betticher DC, Heighway J, Hasleton PS et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer. Br J Cancer 1996; 73: 294-300.
41. Bringuier PP, Tamimi Y, Schuuring E, Schaiken J. Expression of cyclin D1 and EMS1 in bladder tumours: Relationship with chromosome 11q13 amplification. Oncogene 1996; 12: 1747-53.
42. Han EK-H, Sgambato A, Jiang W et al. Stable overexpression of cyclin D1 in human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 1995; 10: 953-61.
43. Parry D, Bates S, Mann DJ et al. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16 INK4/MTS1 tumor suppressor gene product. EMBO J 1995; 14: 503-11.
44. Atadja P, Wong H, Veillete C, Riabowol K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res 1995; 217: 205-16.
45. Freeman RS, Estus S, Johnson EM. Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death. Neuron 1994; 12: 343-55.
46. Dulic V, Drullinger LF, Lees E et al. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: Accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci USA 1993; 90: 11034-8.